Olga Sagalova

A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D

Heiner Wedemeyer, Soo Aleman, Maurizia Rossana Brunetto et al. · New England Journal of Medicine · 2023 · 188 citations · Full text

Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial

Heiner Wedemeyer, Katrin Schöneweis, Pavel Bogomolov et al. · The Lancet Infectious Diseases · 2022 · 138 citations

Hepatology, Viral Hepatitis, Pharmacology +9

The present and future disease burden of hepatitis <scp>C</scp> virus (<scp>HCV</scp>) infections with today's treatment paradigm – volume 2

Angelos Hatzakis, Vladimir Chulanov, Adrián Gadano et al. · Journal of Viral Hepatitis · 2015 · 124 citations · Full text

Viremic Population, Autoimmune Liver Disease, Viral Hepatitis +19

Historical epidemiology of hepatitis C virus (<scp>HCV</scp>) in select countries – volume 2

V A Saraswat, Suzanne Norris, Robert J. de Knegt et al. · Journal of Viral Hepatitis · 2015 · 93 citations · Full text

Hospital‐Based Surveillance of Rotavirus and Other Viral Agents of Diarrhea in Children and Adults in Russia, 2005–2007

E Fenske, N. Yu. Abramycheva, German A. Shipulin et al. · The Journal of Infectious Diseases · 2009 · 75 citations · Full text

Diagnostic Virology, Other Viral Agents, Russian Federation +15